{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T16:31:12Z","timestamp":1790353872543,"version":"4.1.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2018,5,22]],"date-time":"2018-05-22T00:00:00Z","timestamp":1526947200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,5,22]],"date-time":"2018-05-22T00:00:00Z","timestamp":1526947200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Radiation therapy is critical for the control of many tumors and lung is an important dose-limiting organ that impacts radiation dose prescribed to avoid irreversible pulmonary fibrosis in cancer survivors. Idiopathic pulmonary fibrosis (IPF) is a chronic, irreversible lung disease caused by aberrantly activated lung (myo)fibroblasts. The presence of pro-fibrotic, apoptosis-resistant fibroblasts in IPF promotes progressive fibrosis and may have a role in other diseases, if these resistant cells are selected for as a consequence of treatment. However, the pathological response of IPF fibroblasts to radiation compared to non-IPF lung fibroblasts is not known. To address this, we examined fibroblast viability following radiation in lung fibroblasts from IPF and non-IPF patients and the underlying mechanism that protects IPF fibroblasts from radiation-induced death. IPF fibroblasts are significantly more resistant to apoptosis compared to non-IPF lung fibroblasts, suggesting that resistance to radiation-induced cell death is a predominant mechanism leading to lung fibrosis. Analysis of \u03b3H2AX induction demonstrated that radiation-induced DNA damage is reduced in IPF fibroblasts and correlates to the activation of the transcription factor forkhead box M1 (FoxM1) and subsequent upregulation of DNA repair proteins RAD51 and BRCA2. FoxM1 activation occurs secondary to FoxO3a suppression in IPF fibroblasts while restoration of FoxO3a function sensitizes IPF fibroblasts to radiation-induced cell death and downregulates FoxM1, RAD51, and BRCA2. Our findings support that increased FoxO3a\/FoxM1-dependent DNA repair may be integral to the preservation of death-resistant fibrotic fibroblasts after radiation and that selective targeting of radioresistant fibroblasts may mitigate fibrosis.<\/jats:p>","DOI":"10.1038\/s41419-018-0652-4","type":"journal-article","created":{"date-parts":[[2018,5,22]],"date-time":"2018-05-22T05:21:57Z","timestamp":1526966517000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":59,"title":["FoxM1-dependent RAD51 and BRCA2 signaling protects idiopathic pulmonary fibrosis fibroblasts from radiation-induced cell death"],"prefix":"10.1038","volume":"9","author":[{"given":"Jintaek","family":"Im","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Lawrence","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davis","family":"Seelig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard S.","family":"Nho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,5,22]]},"reference":[{"key":"652_CR1","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1016\/j.ijrobp.2006.01.051","volume":"65","author":"FM Kong","year":"2006","unstructured":"Kong, F. M. et al. Final toxicity results of a radiation-dose escalation study in patients with non-small-cell lung cancer (NSCLC): predictors for radiation pneumonitis and fibrosis. Int. J. Radiat. Oncol. Biol. Phys. 65, 1075\u20131086 (2006).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"652_CR2","doi-asserted-by":"publisher","first-page":"e217","DOI":"10.1016\/j.ijrobp.2012.03.067","volume":"84","author":"MH Stenmark","year":"2012","unstructured":"Stenmark, M. H. et al. Combining physical and biologic parameters to predict radiation-induced lung toxicity in patients with non-small-cell lung cancer treated with definitive radiation therapy. Int. J. Radiat. Oncol. Biol. Phys. 84, e217\u2013222 (2012).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"652_CR3","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1016\/j.ijrobp.2007.07.2383","volume":"70","author":"A Takeda","year":"2008","unstructured":"Takeda, A. et al. Possible misinterpretation of demarcated solid patterns of radiation fibrosis on CT scans as tumor recurrence in patients receiving hypofractionated stereotactic radiotherapy for lung cancer. Int. J. Radiat. Oncol. Biol. Phys. 70, 1057\u20131065 (2008).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"652_CR4","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.2174\/1389450111009011386","volume":"11","author":"JP Williams","year":"2010","unstructured":"Williams, J. P., Johnston, C. J. & Finkelstein, J. N. Treatment for radiation-induced pulmonary late effects: spoiled for choice or looking in the wrong direction? Curr. Drug Targets 11, 1386\u20131394 (2010).","journal-title":"Curr. Drug Targets"},{"key":"652_CR5","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.semradonc.2010.01.010","volume":"20","author":"PR Graves","year":"2010","unstructured":"Graves, P. R., Siddiqui, F., Anscher, M. S. & Movsas, B. Radiation pulmonary toxicity: from mechanisms to management. Semin. Radiat. Oncol. 20, 201\u2013207 (2010).","journal-title":"Semin. Radiat. Oncol."},{"key":"652_CR6","doi-asserted-by":"publisher","DOI":"10.1186\/1748-717X-2-21","volume":"2","author":"H Yamashita","year":"2007","unstructured":"Yamashita, H. et al. Exceptionally high incidence of symptomatic grade 2-5 radiation pneumonitis after stereotactic radiation therapy for lung tumors. Radiat. Oncol. 2, 21 (2007).","journal-title":"Radiat. Oncol."},{"key":"652_CR7","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1007\/s00432-012-1284-1","volume":"138","author":"XJ Zhang","year":"2012","unstructured":"Zhang, X. J. et al. Prediction of radiation pneumonitis in lung cancer patients: a systematic review. J. Cancer Res. Clin. Oncol. 138, 2103\u20132116 (2012).","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"652_CR8","doi-asserted-by":"publisher","first-page":"e61017","DOI":"10.1371\/journal.pone.0061017","volume":"8","author":"RS Nho","year":"2013","unstructured":"Nho, R. S., Peterson, M., Hergert, P. & Henke, C. A. FoxO3a (Forkhead Box O3a) deficiency protects idiopathic pulmonary fibrosis (IPF) fibroblasts from type I polymerized collagen matrix-induced apoptosis via caveolin-1 (cav-1) and Fas. PLoS ONE 8, e61017 (2013).","journal-title":"PLoS ONE"},{"key":"652_CR9","doi-asserted-by":"publisher","first-page":"2420","DOI":"10.1016\/j.ajpath.2011.07.020","volume":"179","author":"RS Nho","year":"2011","unstructured":"Nho, R. S., Hergert, P., Kahm, J., Jessurun, J. & Henke, C. Pathological alteration of FoxO3a activity promotes idiopathic pulmonary fibrosis fibroblast proliferation on type i collagen matrix. A. J. Pathol. 179, 2420\u20132430 (2011).","journal-title":"A. J. Pathol."},{"key":"652_CR10","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1002\/path.4749","volume":"240","author":"J Im","year":"2016","unstructured":"Im, J., Kim, K., Hergert, P. & Nho, R. S. Idiopathic pulmonary fibrosis fibroblasts become resistant to Fas ligand-dependent apoptosis via the alteration of decoy receptor 3. J. Pathol. 240, 25\u201337 (2016).","journal-title":"J. Pathol."},{"key":"652_CR11","first-page":"e13020","volume":"4","author":"J Im","year":"2016","unstructured":"Im, J., Kim, K., Yhee, J. Y., O\u2019Grady, S. M. & Nho, R. S. Desensitization of idiopathic pulmonary fibrosis fibroblasts to Alternaria alternata extract-mediated necrotic cell death. Physiol. Rep 4, e13020 (2016).","journal-title":"Rep"},{"key":"652_CR12","doi-asserted-by":"publisher","first-page":"8196","DOI":"10.1074\/jbc.M109.025684","volume":"285","author":"W Chang","year":"2010","unstructured":"Chang, W. et al. SPARC suppresses apoptosis of idiopathic pulmonary fibrosis fibroblasts through constitutive activation of beta-catenin. J. Biol. Chem. 285, 8196\u20138206 (2010).","journal-title":"J. Biol. Chem."},{"key":"652_CR13","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1165\/rcmb.2002-0262OC","volume":"29","author":"YP Moodley","year":"2003","unstructured":"Moodley, Y. P. et al. Inverse effects of interleukin-6 on apoptosis of fibroblasts from pulmonary fibrosis and normal lungs. Am. J. Respir. Cell Mol. Biol. 29, 490\u2013498 (2003).","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"652_CR14","doi-asserted-by":"publisher","first-page":"657","DOI":"10.4236\/abb.2012.326085","volume":"3","author":"TH Sisson","year":"2012","unstructured":"Sisson, T. H. et al. Increased survivin expression contributes to apoptosis-resistance in IPF fibroblasts. Adv. Biosci. Biotechnol. 3, 657\u2013664 (2012).","journal-title":"Adv. Biosci. Biotechnol."},{"key":"652_CR15","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1084\/jem.20110551","volume":"208","author":"TA Wynn","year":"2011","unstructured":"Wynn, T. A. Integrating mechanisms of pulmonary fibrosis. J. Exp. Med. 208, 1339\u20131350 (2011).","journal-title":"J. Exp. Med."},{"key":"652_CR16","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/0360-3016(95)00095-G","volume":"33","author":"P Rubin","year":"1995","unstructured":"Rubin, P., Johnston, C. J., Williams, J. P., McDonald, S. & Finkelstein, J. N. A perpetual cascade of cytokines postirradiation leads to pulmonary fibrosis. Int. J. Radiat. Oncol. Biol. Phys. 33, 99\u2013109 (1995).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"652_CR17","doi-asserted-by":"publisher","first-page":"e53628","DOI":"10.1371\/journal.pone.0053628","volume":"8","author":"C Almeida","year":"2013","unstructured":"Almeida, C. et al. The role of alveolar epithelium in radiation-induced lung injury. PLoS ONE 8, e53628 (2013).","journal-title":"PLoS ONE"},{"key":"652_CR18","doi-asserted-by":"publisher","first-page":"13180","DOI":"10.1073\/pnas.0605669103","volume":"103","author":"KK Kim","year":"2006","unstructured":"Kim, K. K. et al. Alveolar epithelial cell mesenchymal transition develops in vivo during pulmonary fibrosis and is regulated by the extracellular matrix. Proc. Natl Acad. Sci. USA 103, 13180\u201313185 (2006).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"652_CR19","doi-asserted-by":"publisher","first-page":"5501s","DOI":"10.1158\/1078-0432.CCR-07-0980","volume":"13","author":"D Eriksson","year":"2007","unstructured":"Eriksson, D., Lofroth, P. O., Johansson, L., Riklund, K. A. & Stigbrand, T. Cell cycle disturbances and mitotic catastrophes in HeLa Hep2 cells following 2.5 to 10 Gy of ionizing radiation. Clin. Cancer Res. 13, 5501s\u20135508s (2007).","journal-title":"Clin. Cancer Res."},{"key":"652_CR20","doi-asserted-by":"publisher","first-page":"4362","DOI":"10.1038\/sj.onc.1207572","volume":"23","author":"M Castedo","year":"2004","unstructured":"Castedo, M. et al. Mitotic catastrophe constitutes a special case of apoptosis whose suppression entails aneuploidy. Oncogene 23, 4362\u20134370 (2004).","journal-title":"Oncogene"},{"key":"652_CR21","doi-asserted-by":"publisher","first-page":"2825","DOI":"10.1038\/sj.onc.1207528","volume":"23","author":"M Castedo","year":"2004","unstructured":"Castedo, M. et al. Cell death by mitotic catastrophe: a molecular definition. Oncogene 23, 2825\u20132837 (2004).","journal-title":"Oncogene"},{"key":"652_CR22","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/s13277-010-0042-8","volume":"31","author":"D Eriksson","year":"2010","unstructured":"Eriksson, D. & Stigbrand, T. Radiation-induced cell death mechanisms. Tumour Biol. 31, 363\u2013372 (2010).","journal-title":"Tumour Biol."},{"key":"652_CR23","first-page":"4361","volume":"29","author":"D Eriksson","year":"2009","unstructured":"Eriksson, D., Lofroth, P. O., Johansson, L., Riklund, K. & Stigbrand, T. Apoptotic signalling in HeLa Hep2 cells following 5 Gy of cobalt-60 gamma radiation. Anticancer Res. 29, 4361\u20134366 (2009).","journal-title":"Anticancer Res."},{"key":"652_CR24","unstructured":"Hall, E. J. & Giaccia, A. J. Radiobiology for the Radiologist 7th edn (Lippincott Williams & Wilkins: Philadelphia, 2011)."},{"key":"652_CR25","doi-asserted-by":"publisher","first-page":"4117","DOI":"10.1158\/0008-5472.CAN-04-3071","volume":"65","author":"C Abaji","year":"2005","unstructured":"Abaji, C., Cousineau, I. & Belmaaza, A. BRCA2 regulates homologous recombination in response to DNA damage: implications for genome stability and carcinogenesis. Cancer Res. 65, 4117\u20134125 (2005).","journal-title":"Cancer Res."},{"key":"652_CR26","doi-asserted-by":"publisher","first-page":"2581","DOI":"10.1101\/gad.289439.116","volume":"30","author":"K Luo","year":"2016","unstructured":"Luo, K. et al. A phosphorylation-deubiquitination cascade regulates the BRCA2-RAD51 axis in homologous recombination. Genes Dev. 30, 2581\u20132595 (2016).","journal-title":"Genes Dev."},{"key":"652_CR27","doi-asserted-by":"publisher","first-page":"164","DOI":"10.2174\/1389450115666141122211549","volume":"17","author":"G Nestal de Moraes","year":"2016","unstructured":"Nestal de Moraes, G., Bella, L., Zona, S., Burton, M. J. & Lam, E. W. Insights into a critical role of the FoxO3a\u2013FoxM1 axis in DNA damage response and genotoxic drug resistance. Curr. Drug Targets 17, 164\u2013177 (2016).","journal-title":"Curr. Drug Targets"},{"key":"652_CR28","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1128\/MCB.01068-06","volume":"27","author":"Y Tan","year":"2007","unstructured":"Tan, Y., Raychaudhuri, P. & Costa, R. H. Chk2 mediates stabilization of the FoxM1 transcription factor to stimulate expression of DNA repair genes. Mol. Cell Biol. 27, 1007\u20131016 (2007).","journal-title":"Mol. Cell Biol."},{"key":"652_CR29","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1038\/emboj.2012.336","volume":"32","author":"D Balli","year":"2013","unstructured":"Balli, D. et al. FoxM1 transcription factor is required for lung fibrosis and epithelial-to-mesenchymal transition. EMBO J. 32, 231\u2013244 (2013).","journal-title":"EMBO J."},{"key":"652_CR30","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1038\/onc.2011.368","volume":"31","author":"CT Karadedou","year":"2012","unstructured":"Karadedou, C. T. et al. FoxO3a represses VEGF expression through FoxM1-dependent and -independent mechanisms in breast cancer. Oncogene 31, 1845\u20131858 (2012).","journal-title":"Oncogene"},{"key":"652_CR31","doi-asserted-by":"publisher","first-page":"L632","DOI":"10.1152\/ajplung.00127.2014","volume":"307","author":"RS Nho","year":"2014","unstructured":"Nho, R. S., Im, J., Ho, Y. Y. & Hergert, P. MicroRNA-96 inhibits FoxO3a function in IPF fibroblasts on type I collagen matrix. Am. J. Physiol. Lung Cell Mol. Physiol. 307, L632\u2013642 (2014).","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"652_CR32","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1158\/1078-0432.CCR-14-0846","volume":"21","author":"T Yoshida.","year":"2015","unstructured":"Yoshida., T. et al. Podoplanin-positive cancer-associated fibroblasts in the tumor microenvironment induce primary resistance to EGFR-TKIs in lung adenocarcinoma with EGFR mutation. Clin. Cancer Res. 21, 642\u2013651 (2015).","journal-title":"Clin. Cancer Res."},{"key":"652_CR33","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1083\/jcb.146.5.905","volume":"146","author":"EP Rogakou","year":"1999","unstructured":"Rogakou, E. P., Boon, C., Redon, C. & Bonner, W. M. Megabase chromatin domains involved in DNA double-strand breaks in vivo. J. Cell Biol. 146, 905\u2013916 (1999).","journal-title":"J. Cell Biol."},{"key":"652_CR34","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1038\/nrc2523","volume":"8","author":"WM Bonner.","year":"2008","unstructured":"Bonner., W. M. et al. Gamma-H2AX and cancer. Gamma-H2AX and cancer. Nat. Rev. Cancer 8, 957\u2013967 (2008).","journal-title":"Nat. Rev. Cancer"},{"key":"652_CR35","doi-asserted-by":"publisher","first-page":"5858","DOI":"10.1074\/jbc.273.10.5858","volume":"273","author":"EP Rogakou","year":"1998","unstructured":"Rogakou, E. P., Pilch, D. R., Orr, A. H., Ivanova, V. S. & Bonner, W. M. DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139. J. Biol. Chem. 273, 5858\u20135868 (1998).","journal-title":"J. Biol. Chem."},{"key":"652_CR36","first-page":"305","volume":"22","author":"LJ Kuo","year":"2008","unstructured":"Kuo, L. J. & Yang, L. X. Gamma-H2AX\u2014a novel biomarker for DNA double-strand breaks. Vivo 22, 305\u2013309 (2008).","journal-title":"Vivo"},{"key":"652_CR37","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.radonc.2014.03.011","volume":"111","author":"E Flockerzi","year":"2014","unstructured":"Flockerzi, E., Schanz, S. & Rube, C. E. Even low doses of radiation lead to DNA damage accumulation in lung tissue according to the genetically-defined DNA repair capacity. Radiother. Oncol. 111, 212\u2013218 (2014).","journal-title":"Radiother. Oncol."},{"key":"652_CR38","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1093\/jnci\/djt212","volume":"105","author":"DE Citrin","year":"2013","unstructured":"Citrin, D. E. et al. Role of type II pneumocyte senescence in radiation-induced lung fibrosis. J. Natl Cancer Inst. 105, 1474\u20131484 (2013).","journal-title":"J. Natl Cancer Inst."},{"key":"652_CR39","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1097\/MCP.0000000000000217","volume":"21","author":"KM Antoniou","year":"2015","unstructured":"Antoniou, K. M., Tomassetti, S., Tsitoura, E. & Vancheri, C. Idiopathic pulmonary fibrosis and lung cancer: a clinical and pathogenesis update. Curr. Opin. Pulm. Med. 21, 626\u2013633 (2015).","journal-title":"Curr. Opin. Pulm. Med."},{"key":"652_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pupt.2017.03.016","volume":"45","author":"T Karampitsakos.","year":"2017","unstructured":"Karampitsakos., T. et al. Lung cancer in patients with idiopathic pulmonary fibrosis. Pulm. Pharmacol. Ther. 45, 1\u201310 (2017).","journal-title":"Pulm. Pharmacol. Ther."},{"key":"652_CR41","doi-asserted-by":"crossref","first-page":"3142","DOI":"10.3760\/cma.j.issn.0366-6999.20141346","volume":"127","author":"J Li","year":"2014","unstructured":"Li, J. et al. Idiopathic pulmonary fibrosis will increase the risk of lung cancer. Chin. Med. J. 127, 3142\u20133149 (2014).","journal-title":"Chin. Med. J."},{"key":"652_CR42","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1016\/S0140-6736(17)30866-8","volume":"389","author":"L Richeldi","year":"2017","unstructured":"Richeldi, L., Collard, H. R. & Jones, M. G. Idiopathic pulmonary fibrosis. Lancet 389, 1941\u20131952 (2017).","journal-title":"Lancet"},{"key":"652_CR43","first-page":"17","volume":"32","author":"C Vancheri","year":"2015","unstructured":"Vancheri, C., Cottin, V., Kreuter, M. & Hilberg, O. IPF, comorbidities and management implications. Sarcoidosis Vasc. Diffus. Lung Dis. 32, 17\u201323 (2015).","journal-title":"Sarcoidosis Vasc. Diffus. Lung Dis."},{"key":"652_CR44","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1158\/1541-7786.MCR-15-0307","volume":"14","author":"D Pankova","year":"2016","unstructured":"Pankova, D. et al. Cancer-associated fibroblasts induce a collagen cross-link switch in tumor stroma. Mol. Cancer Res. 14, 287\u2013295 (2016).","journal-title":"Mol. Cancer Res."},{"key":"652_CR45","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.semcancer.2014.02.006","volume":"25","author":"J Paulsson","year":"2014","unstructured":"Paulsson, J. & Micke, P. Prognostic relevance of cancer-associated fibroblasts in human cancer. Semin. Cancer Biol. 25, 61\u201368 (2014).","journal-title":"Semin. Cancer Biol."},{"key":"652_CR46","doi-asserted-by":"publisher","first-page":"365","DOI":"10.5732\/cjc.012.10277","volume":"32","author":"AR Gomes","year":"2013","unstructured":"Gomes, A. R., Zhao, F. & Lam, E. W. Role and regulation of the forkhead transcription factors FoxO3a and FoxM1 in carcinogenesis and drug resistance. Chin. J. Cancer 32, 365\u2013370 (2013).","journal-title":"Chin. J. Cancer"},{"key":"652_CR47","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1007\/s11684-012-0228-0","volume":"6","author":"F Zhao","year":"2012","unstructured":"Zhao, F. & Lam, E. W. Role of the forkhead transcription factor FoxO-FoxM1 axis in cancer and drug resistance. Front. Med. 6, 376\u2013380 (2012).","journal-title":"Front. Med."},{"key":"652_CR48","doi-asserted-by":"publisher","first-page":"3135","DOI":"10.1158\/0008-5472.CAN-16-3566","volume":"77","author":"AL Gartel","year":"2017","unstructured":"Gartel, A. L. FoxM1 in cancer: Interactions and vulnerabilities. Cancer Res. 77, 3135\u20133139 (2017).","journal-title":"Cancer Res."},{"key":"652_CR49","doi-asserted-by":"crossref","first-page":"32298","DOI":"10.18632\/oncotarget.15764","volume":"8","author":"L Li","year":"2017","unstructured":"Li, L., Wu, D., Yu, Q., Li, L. & Wu, P. Prognostic value of FoxM1 in solid tumors: a systematic review and meta-analysis. Oncotarget 8, 32298\u201332308 (2017).","journal-title":"Oncotarget"},{"key":"652_CR50","doi-asserted-by":"publisher","first-page":"9768183","DOI":"10.1155\/2016\/9768183","volume":"2016","author":"R Saba.","year":"2016","unstructured":"Saba., R., Alsayed, A., Zacny, J. P. & Dudek, A. Z. The role of forkhead box protein M1 in breast cancer progression and resistance to therapy. Int. J. Breast Cancer 2016, 9768183 (2016).","journal-title":"Int. J. Breast Cancer"},{"key":"652_CR51","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1084\/jem.20080001","volume":"205","author":"H Xia","year":"2008","unstructured":"Xia, H. et al. Pathological integrin signaling enhances proliferation of primary lung fibroblasts from patients with idiopathic pulmonary fibrosis. J. Exp. Med. 205, 1659\u20131672 (2008).","journal-title":"J. Exp. Med."},{"key":"652_CR52","doi-asserted-by":"publisher","first-page":"33024","DOI":"10.1074\/jbc.M313265200","volume":"279","author":"H Xia","year":"2004","unstructured":"Xia, H., Nho, R. S., Kahm, J., Kleidon, J. & Henke, C. A. Focal adhesion kinase is upstream of phosphatidylinositol 3-kinase\/Akt in regulating fibroblast survival in response to contraction of type I collagen matrices via a beta 1 integrin viability signaling pathway. J. Biol. Chem. 279, 33024\u201333034 (2004).","journal-title":"J. Biol. Chem."}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-0652-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-0652-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-0652-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,6]],"date-time":"2024-07-06T18:29:33Z","timestamp":1720290573000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-0652-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,22]]},"references-count":52,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2018,6]]}},"alternative-id":["652"],"URL":"https:\/\/doi.org\/10.1038\/s41419-018-0652-4","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,22]]},"assertion":[{"value":"8 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"584"}}